Hosted on MSN3mon
23andMe’s stock falls after company says there’s substantial doubt it can stay in businessbased 23andMe posted a net loss of $59 million in its fiscal second quarter to Sept. 30, narrower than the loss of $75 million posted in the year-earlier period. Revenue came to $44 million ...
Hosted on MSN4mon
With 23andMe's future unclear, what will happen to users' data? Here's how to delete it23andMe is on the brink of a financial collapse. The company – founded in 2006 – is now considered unprofitable, The Wall Street Journal reported. Despite generating $299 million in revenue in ...
The DNA-testing company is exploring its options, including a business combination and the sale of some or all of its assets.
23andMe Reports Q3 FY25 Financial Results Amid Ongoing Liquidity Concerns and Operational Challenges
In Q3 FY25, 23andMe reported total revenue of $60.3 million, primarily driven by $19.3 million from non-recurring research services revenue. What cost-cutting measures has 23andMe implemented?
23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.
23andMe ended December 31 ... or take other actions. Total Revenue for FY25 Q3 was $60.3 million, compared to $44.7 million for the same period in the prior year. The increase was primarily ...
The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data breach last year that specifically targeted customers of Ashkenazi Jewish ...
23andMe is considering a sale of the company ... DNA testing kits are mostly a one-time purchase, limiting long-term revenue. Additionally, despite possessing one of the largest DNA databases ...
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and ...
23andMe has no debt on its balance sheet ... Such improvement was due to the reasons discussed above, primarily the Non-Recurring Revenue Recognition and the FY24 Q3 Impairment Charge.
23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results